Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

This study has been completed.
Sponsor:
Collaborators:
German Research Foundation
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Joerg Schirra, Ludwig-Maximilians - University of Munich
ClinicalTrials.gov Identifier:
NCT00393445
First received: October 26, 2006
Last updated: October 2, 2011
Last verified: October 2011